Richard D. DiMarchi - 25 May 2022 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Reporting relationship: Director
Issuer ticker: ASMB
Reported as of: 25 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 May 2022, 16:31:01 UTC
Prior SEC filing: 24 May 2021
Source filing: View source filing
Reporting owner signature: /s/ John O. Gunderson, as Attorney-in-Fact

Key filing fact

Richard D. DiMarchi filed Form 4 for ASSEMBLY BIOSCIENCES, INC. (ASMB) on 27 May 2022.

Key facts

This page summarizes Richard D. DiMarchi's Form 4 filing for ASSEMBLY BIOSCIENCES, INC. (ASMB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 May 2022, 16:31.

Change

Previous filing in this sequence was filed on 24 May 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ASMB transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +20,000
Change %
Price: $0.000000
Shares after: 20,000
Date: 25 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $1.69
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 25, 2023 and (2) the date of the Issuer's 2023 annual meeting of stockholders.